Graham G. Walmsley (CIK 0001777517)

Latest company ownership

Shares held
1,800,000
Last filed at
May 13, 2025
Confidence Score
49.9
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
1,200,000
Last filed at
Oct 10, 2025
Confidence Score
50.6
2025Q4
Confidence Score History
2022Q3 2025Q4
Shares held
12,004
Last filed at
Jun 15, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 25, 2025 Mar 27, 2025 Akero Therapeutics, Inc. Director Buy 100.0 +200,000 19.96% ✗ $8.8M
Jan 30, 2025 Feb 7, 2025 Akero Therapeutics, Inc. Director Buy 100.0 +200,000 24.93% ✗ $9.6M
Dec 17, 2024 Dec 17, 2024 Olema Pharmaceuticals, Inc. Director Sell 16.3 -1,401,522 -49.87% ✗ $9.5M
Jun 4, 2024 Nov 26, 2024 Olema Pharmaceuticals, Inc. Director Sell 15.0 -1,175,000 -45.47% ✗ $17.4M
Jun 4, 2024 Jun 6, 2024 Olema Pharmaceuticals, Inc. Director Sell 15.0 -1,175,000 -45.47% ✗ $17.4M
Sep 12, 2023 Dec 18, 2023 Olema Pharmaceuticals, Inc. Director Buy 100.0 +640,000 55.17% ✗ $6.9M
Dec 8, 2023 Dec 11, 2023 Akero Therapeutics, Inc. Director Buy 100.0 +100,000 14.24% ✗ $2M
Nov 30, 2023 Dec 5, 2023 Akero Therapeutics, Inc. Director Buy 100.0 +100,000 16.61% ✗ $1.7M
Aug 8, 2023 Aug 10, 2023 Akero Therapeutics, Inc. Director Buy 92.5 +25,000 4.33% ✗ $1.1M
Jul 28, 2023 Aug 1, 2023 Akero Therapeutics, Inc. Director Buy 100.0 +55,000 10.53% ✗ $2.4M
Sep 19, 2022 Jun 15, 2023 Akero Therapeutics, Inc. Director Buy 100.0 +520,000 23985.24% ✗ $15.4M
Sep 19, 2023 May 23, 2023 Akero Therapeutics, Inc. Director Buy 100.0 +520,000 129.30% ✗ $15.4M
Dec 14, 2020 Dec 15, 2020 ALX ONCOLOGY HOLDINGS INC Director Buy 87.5 +20,000 2.05% ✗ $1.5M
Nov 23, 2020 Nov 23, 2020 Olema Pharmaceuticals, Inc. Director Buy 100.0 +1,160,000 100.00% ✗ $22M
Jul 21, 2020 Jul 21, 2020 ALX ONCOLOGY HOLDINGS INC Director Buy 100.0 +975,000 100.00% ✗ $18.5M